glp 1 receptor agonists in idiopathic intracranial hypertension Use of glucagon-like peptide-1 : a systematic review | The Journal of Headache and Pain The effect of GLP-1 agonist

The TRIUMPH-1 trial enrolled adults with a BMI of 30 or above, or a BMI of at least 27 plus a weight-related health condition

Activation of these receptors during glucose regulation helps improve -cell function and protect the pancreas, enhancing insulin secretion and better controlling blood glucose levels

Eng personally secured a patent and partnered with Amylin, leading to the FDA-approved diabetes drug exenatide in 2005, the first GLP-1 analog

Furness, J

The expanding benefits of GLP-1 medicines

One GLP-1 drug, known as albiglutide, which was withdrawn from the market with only a modest effect on weight loss, nonetheless reduced the rates of major adverse cardiovascular events by 22%